Continuous Glucose Monitoring Devices Market Set to Witness Significant Growth by 2025-2032 | Medtronic, Dexcom, Inc., Abbott, Novo Nordisk A/S

Continuous Glucose Monitoring Devices Market Size, Trends, and Growth Forecast 2025-2032

The Continuous Glucose Monitoring (CGM) devices industry is advancing rapidly as diabetes management evolves toward real-time, minimally invasive glucose monitoring solutions. Innovations in sensor technology, coupled with integration in digital health platforms, are fueling the CGM device market growth, driving shifts in patient care paradigms and expanding adoption across global healthcare systems.

Market Size and Overview

The Global Continuous Glucose Monitoring Devices Market size is estimated to be valued at USD 7.81 billion in 2025 and is expected to reach USD 15.43 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032. This market growth forecast reflects increasing diabetes prevalence, technological enhancements, and growing demand for accurate glucose level tracking, crucial for effective diabetes management. Recent regulatory approvals and reimbursement policies are also expanding the market scope worldwide.

Key Takeaways

- North America: Leading adoption driven by advanced healthcare infrastructure and reimbursement frameworks, fostering industry share growth in CGM devices market.
- Latin America: Emerging markets witnessing steady growth due to increasing diabetes awareness and healthcare modernization initiatives.
- Europe: Mature market with a focus on integration of CGM with mobile applications and personalized treatment, bolstering market revenue.
- Asia Pacific: Fastest-growing region propelled by rising diabetes population and increased healthcare spending, presenting substantial market opportunities.
- Middle East and Africa: Developing healthcare systems and increased government initiatives supporting access to CGM devices contribute to market presence.

Request a Sample of the Continuous Glucose Monitoring Devices Analysis Report ! https://www.coherentmarketinsights.com/insight/request-sample/57

Segment Covers:

- Device Type:
- Real-time CGM (rtCGM) - Preferred for continuous data stream aiding immediate clinical decisions, extensively used in hospitals.
- Intermittently-scanned CGM (isCGM) - Gaining traction for ease of use and cost-effectiveness in outpatient settings.

End User:
- Hospitals and Clinics - High usage due to critical patient monitoring requirements.
- Home Care - Rising adoption with user-friendly devices enabling remote disease management.

Application:
- Type 1 Diabetes Management - Largest application segment demanding precise glucose insights.
- Type 2 Diabetes Monitoring - Growing segment fueled by preventive healthcare strategies and rising incidence rates.

Growth Factors

- Rising global diabetes incidence, with WHO reporting over 537 million adults living with diabetes in 2023, is a principal growth driver for the CGM devices market size.
- Advances in sensor accuracy and miniaturization have reduced device-related discomfort, improving patient compliance substantially; a 2024 clinical study indicated a 20% increase in adherence with latest-generation CGM devices.
- Increasing integration of CGM systems with smartphone apps and artificial intelligence for predictive analytics is expanding market opportunities, especially in North America and Asia Pacific regions.

Market Trends

- Expansion in cloud-based data analytics platforms supporting continuous monitoring is becoming a dominant market trend, providing personalized insights and facilitating remote patient management. For instance, a 2024 data release showed a 35% increase in CGM data use for telemedicine consultations globally.
- Hybrid closed-loop insulin delivery systems incorporating CGM sensors are gaining momentum, marking a shift toward automated diabetes management solutions.
- Growing emphasis on device interoperability standards and patient data security defines an emerging trend impacting market players' product development strategies.

Actionable Insights

- Supply-Side Indicators: Production capacity of leading CGM devices increased by 18% in 2024, addressing rising demand and reducing lead times. Pricing dynamics have stabilized, with average device prices dropping by 7% due to technological advancements and competitive product launches. Exports to emerging markets increased by 22%, reflecting expanding international market penetration.
- Demand-Side Indicators: Import volumes for CGM sensors surged 25% in Asia Pacific during 2025, mainly driven by increasing home-care adoption. Usage statistics indicate that hospital-based CGM adoption increased by 15% in Europe due to updated clinical guidelines. Various use cases now include gestational diabetes monitoring, adding to market scale and diversity.

Request a Sample Copy: ! https://www.coherentmarketinsights.com/insight/request-sample/57

Key Players

- Dexcom
- Abbott Laboratories
- Medtronic
- Senseonics Holdings
- Insulet Corporation
- Roche Diabetes Care
- Ascensia Diabetes Care
- Tandem Diabetes Care
- Nipro Corporation
- Ypsomed Holding AG
- A. Menarini Diagnostics
- i-SENS, Inc.
- B. Braun Melsungen AG
- Agamatrix, Inc.
- Ascensia Diabetes Care
- Ascensia Diabetes Care
- Silicon Biosystems
- Eversense
- AgaMatrix

Competitive strategies include Dexcom's strategic collaboration with smartphone manufacturers to enhance device app compatibility, leading to a 30% revenue increase in 2024. Abbott launched new marketing campaigns targeting younger diabetic populations, enhancing market penetration, especially in the Asia Pacific. Medtronic's acquisition of novel biosensor startups in 2024 has bolstered its portfolio with next-generation CGM technology, improving competitive positioning.

FAQs

1. Who are the dominant players in the Continuous Glucose Monitoring Devices market?
Dominant players include Dexcom, Abbott Laboratories, Medtronic, and Senseonics Holdings, each leveraging technology innovation, strategic partnerships, and product expansion to maintain leadership positions.

2. What will be the size of the Continuous Glucose Monitoring Devices market in the coming years?
The market size is projected to grow from USD 7.81 billion in 2025 to approximately USD 15.43 billion by 2032, reflecting a 9.9% CAGR during this period.

3. Which end-user industry has the largest growth opportunity?
Home healthcare and outpatient diabetes management sectors show the largest growth due to increased patient preference for remote monitoring and convenience.

4. How will market development trends evolve over the next five years?
There will be a gradual shift toward hybrid closed-loop devices, greater data interoperability, and widespread adoption of cloud-based analytics, amplifying the utility and accuracy of CGM systems.

5. What is the nature of the competitive landscape and challenges in the Continuous Glucose Monitoring Devices market?
The competitive landscape is characterized by technological innovation, aggressive market penetration strategies, and increased focus on data security. Regulatory hurdles and reimbursement variability remain key market restraints.

Get Up to 25% Discount on Continuous Glucose Monitoring Devices Analysis Report ! https://www.coherentmarketinsights.com/insight/buy-now/57

Table of Content: Continuous Glucose Monitoring Devices Market Scenario 2025

1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social, and Technological) Analysis of Continuous Glucose Monitoring Devices Industry
2 Market Trends and Competitive Landscape
3 Segmentation of Continuous Glucose Monitoring Devices Market by Types
4 Segmentation by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Continuous Glucose Monitoring Devices Industry in Major Countries
7 North America Continuous Glucose Monitoring Devices Landscape Analysis
8 Europe Continuous Glucose Monitoring Devices Landscape Analysis
9 Asia Pacific Continuous Glucose Monitoring Devices Landscape Analysis
10 Latin America, Middle East & Africa Continuous Glucose Monitoring Devices Landscape Analysis
11 Major Players Profile

Author of this marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837

About CMI:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

This release was published on openPR.